A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function

RUDOLPH, V., RUDOLPH, T.K., KUBALA, Lukáš, CLAUBERG, N., MAAS, R., PEKAROVÁ, Michaela, KLINKE, A., LAU, D., SZÖCS, K., MEINERTZ, T., BÖGER, R.H., BALDUS, S. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function. Free Radical Biology and Medicine. 2009, 47(11), 1584-1590. ISSN 0891-5849. E-ISSN 1873-4596. Available: doi: 10.1016/j.freeradbiomed.2009.09.001